Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Clinical trial NCT05681273 · COMPLETED
Trial details
- NCT number
- NCT05681273
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-17
- Primary completion
- 2023-03-21
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.